169 related articles for article (PubMed ID: 37663943)
1. Potential of damage associated molecular patterns in synergising radiation and the immune response in oesophageal cancer.
Donlon NE; Davern M; Sheppard A; O'Connell F; Moran B; Nugent TS; Heeran A; Phelan JJ; Bhardwaj A; Butler C; Ravi N; Donohoe CL; Lynam-Lennon N; Maher S; Reynolds JV; Lysaght J
World J Gastrointest Oncol; 2023 Aug; 15(8):1349-1365. PubMed ID: 37663943
[TBL] [Abstract][Full Text] [Related]
2. Impact of radiotherapy on the immune landscape in oesophageal adenocarcinoma.
Donlon NE; Davern M; O'Connell F; Sheppard A; Heeran A; Bhardwaj A; Butler C; Narayanasamy R; Donohoe C; Phelan JJ; Lynam-Lennon N; Dunne MR; Maher S; O'Sullivan J; Reynolds JV; Lysaght J
World J Gastroenterol; 2022 Jun; 28(21):2302-2319. PubMed ID: 35800186
[TBL] [Abstract][Full Text] [Related]
3. Nutrient deprivation and hypoxia alter T cell immune checkpoint expression: potential impact for immunotherapy.
Davern M; Donlon NE; O'Connell F; Gaughan C; O'Donovan C; McGrath J; Sheppard AD; Hayes C; King R; Temperley H; MacLean M; Bulter C; Bhardwaj A; Moore J; Donohoe C; Ravi N; Conroy MJ; Reynolds JV; Lysaght J
J Cancer Res Clin Oncol; 2023 Jul; 149(8):5377-5395. PubMed ID: 36445478
[TBL] [Abstract][Full Text] [Related]
4. Damage-associated molecular patterns (DAMPs) related to immunogenic cell death are differentially triggered by clinically relevant chemotherapeutics in lung adenocarcinoma cells.
Solari JIG; Filippi-Chiela E; Pilar ES; Nunes V; Gonzalez EA; Figueiró F; Andrade CF; Klamt F
BMC Cancer; 2020 May; 20(1):474. PubMed ID: 32456685
[TBL] [Abstract][Full Text] [Related]
5. Increased plasma levels of damage-associated molecular patterns during systemic anticancer therapy in patients with advanced lung cancer.
Inoue H; Tsutsumi H; Tanaka K; Iwama E; Shiraishi Y; Hirayama A; Nakanishi T; Ando H; Nakajima M; Shinozaki S; Ogata H; Uryu K; Okamura K; Kimura S; Ogawa T; Ota K; Yoneshima Y; Hamada N; Nakanishi Y; Okamoto I
Transl Lung Cancer Res; 2021 Jun; 10(6):2475-2486. PubMed ID: 34295655
[TBL] [Abstract][Full Text] [Related]
6. Impact of increased plasma levels of calreticulin on prognosis of patients with advanced lung cancer undergoing combination treatment of chemotherapy and immune checkpoint inhibitors.
Tsutsumi H; Inoue H; Shiraishi Y; Hirayama A; Nakanishi T; Ando H; Nakajima M; Shinozaki S; Ogata H; Okamura K; Kimura S; Ogawa T; Ota K; Yoneshima Y; Tanaka K; Hamada N; Okamoto I; Iwama E
Lung Cancer; 2023 Jul; 181():107264. PubMed ID: 37276707
[TBL] [Abstract][Full Text] [Related]
7. The Prognostic Value of the Lymph Node in Oesophageal Adenocarcinoma; Incorporating Clinicopathological and Immunological Profiling.
Donlon NE; Davern M; Sheppard A; Power R; O'Connell F; Heeran AB; King R; Hayes C; Bhardwaj A; Phelan JJ; Dunne MR; Ravi N; Donohoe CL; O'Sullivan J; Reynolds JV; Lysaght J
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439160
[TBL] [Abstract][Full Text] [Related]
8. Identification of plasma proteins associated with oesophageal cancer chemotherapeutic treatment outcomes using SWATH-MS.
Guo N; Minas G; Synowsky SA; Dunne MR; Ahmed H; McShane R; Bhardwaj A; Donlon NE; Lorton C; O'Sullivan J; Reynolds JV; Caie PD; Shirran SL; Lynch AG; Stewart AJ; Arya S
J Proteomics; 2022 Aug; 266():104684. PubMed ID: 35842220
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory DAMPs in immunogenic cell death and its clinical implications.
Hayashi K; Nikolos F; Chan KS
Cell Stress; 2021 Mar; 5(4):52-54. PubMed ID: 33821233
[TBL] [Abstract][Full Text] [Related]
10. Prognostic and Predictive Value of DAMPs and DAMP-Associated Processes in Cancer.
Fucikova J; Moserova I; Urbanova L; Bezu L; Kepp O; Cremer I; Salek C; Strnad P; Kroemer G; Galluzzi L; Spisek R
Front Immunol; 2015; 6():402. PubMed ID: 26300886
[TBL] [Abstract][Full Text] [Related]
11. The novel immunomodulator IMMUNEPOTENT CRP combined with chemotherapy agent increased the rate of immunogenic cell death and prevented melanoma growth.
Rodríguez-Salazar MDC; Franco-Molina MA; Mendoza-Gamboa E; Martínez-Torres AC; Zapata-Benavides P; López-González JS; Coronado-Cerda EE; Alcocer-González JM; Tamez-Guerra RS; Rodríguez-Padilla C
Oncol Lett; 2017 Jul; 14(1):844-852. PubMed ID: 28693241
[TBL] [Abstract][Full Text] [Related]
12. Nano-Pulse Stimulation is a physical modality that can trigger immunogenic tumor cell death.
Nuccitelli R; McDaniel A; Anand S; Cha J; Mallon Z; Berridge JC; Uecker D
J Immunother Cancer; 2017; 5():32. PubMed ID: 28428881
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic chemotherapeutic agents and the EGFR-TKI osimertinib induce calreticulin exposure in non-small cell lung cancer.
Furukawa R; Inoue H; Yoneshima Y; Tsutsumi H; Iwama E; Ikematsu Y; Ando N; Shiraishi Y; Ota K; Tanaka K; Nakanishi Y; Okamoto I
Lung Cancer; 2021 May; 155():144-150. PubMed ID: 33819860
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-330-5p as a Putative Modulator of Neoadjuvant Chemoradiotherapy Sensitivity in Oesophageal Adenocarcinoma.
Bibby BA; Reynolds JV; Maher SG
PLoS One; 2015; 10(7):e0134180. PubMed ID: 26221725
[TBL] [Abstract][Full Text] [Related]
15. Altered mitochondrial function and energy metabolism is associated with a radioresistant phenotype in oesophageal adenocarcinoma.
Lynam-Lennon N; Maher SG; Maguire A; Phelan J; Muldoon C; Reynolds JV; O'Sullivan J
PLoS One; 2014; 9(6):e100738. PubMed ID: 24968221
[TBL] [Abstract][Full Text] [Related]
16. Effects of Electrochemotherapy on Immunologically Important Modifications in Tumor Cells.
Kesar U; Markelc B; Jesenko T; Ursic Valentinuzzi K; Cemazar M; Strojan P; Sersa G
Vaccines (Basel); 2023 Apr; 11(5):. PubMed ID: 37243029
[TBL] [Abstract][Full Text] [Related]
17. Visceral Adipose Tissue Modulates Radiosensitivity in Oesophageal Adenocarcinoma.
Mongan AM; Lynam-Lennon N; Doyle SL; Casey R; Carr E; Cannon A; Conroy MJ; Pidgeon GP; Brennan L; Lysaght J; Reynolds JV; O'Sullivan J
Int J Med Sci; 2019; 16(4):519-528. PubMed ID: 31171903
[TBL] [Abstract][Full Text] [Related]
18. Increased Plasma Levels of Danger-Associated Molecular Patterns Are Associated With Immune Suppression and Postoperative Infections in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
Leijte GP; Custers H; Gerretsen J; Heijne A; Roth J; Vogl T; Scheffer GJ; Pickkers P; Kox M
Front Immunol; 2018; 9():663. PubMed ID: 29675023
[TBL] [Abstract][Full Text] [Related]
19. Immunogenic cell death, DAMPs and anticancer therapeutics: an emerging amalgamation.
Garg AD; Nowis D; Golab J; Vandenabeele P; Krysko DV; Agostinis P
Biochim Biophys Acta; 2010 Jan; 1805(1):53-71. PubMed ID: 19720113
[TBL] [Abstract][Full Text] [Related]
20. PI3K inhibition as a novel therapeutic strategy for neoadjuvant chemoradiotherapy resistant oesophageal adenocarcinoma.
Edge SD; Renard I; Pyne E; Li C; Moody H; Roy R; Beavis AW; Archibald SJ; Cawthorne CJ; Maher SG; Pires IM
Br J Radiol; 2021 Mar; 94(1119):20201191. PubMed ID: 33434085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
